Sanofi Consumer Healthcare India Ltd Reports Q1 Results with PAT up by 12.9%

Sanofi Consumer Healthcare India Ltd. announced its Q1 results with PAT at 500 million, a 12.9% increase from the last quarter of Q4 2024. The EPS stands at 21.7 with an increase of 2.4 per share. The company reported revenue from operations of 1726 million. The Q1 2025 also witnessed a successful launch of Allegra D, an addition to the existing portfolio of Allegra variants in India. The Q1 2025 and Q1 2024 are not directly comparable due to demerger and voluntary product recall of certain variants of key brands.